Related Experiment Video
Updated: Oct 4, 2025
06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
3.0K
Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia
Mariangela Scarduzio1, Ellen J Hess2, David G Standaert1
1Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Neurobiology of Disease
|February 9, 2022
Summary
This review explores synaptic dysfunction and neurochemical changes in hyperkinetic movement disorders like dystonia and dyskinesia. Understanding these synaptic alterations is key to developing new treatments for these conditions.
Area of Science:
- Neuroscience
- Movement Disorders
Background:
- Hyperkinetic movement disorders, including dystonia and dyskinesia, are characterized by involuntary movements.
- Synaptic function and plasticity are crucial for normal motor control.
Purpose of the Study:
- To review synaptic dysfunctions and neurochemical alterations in dystonia and dyskinesia.
- To highlight similarities in synaptic plasticity and neuromodulation changes in these disorders.
Main Methods:
- Literature review of synaptic changes in hyperkinetic movement disorders.
- Analysis of alterations in neurotransmitter systems and neuromodulators.
Main Results:
- Observed changes in physical synapse attributes and synaptic protein expression.
- Alterations in glutamate, GABA, dopamine, acetylcholine, serotonin, adenosine, and endocannabinoid systems.
Conclusions:
- Synaptic dysfunctions and neurochemical alterations are common in dystonia and dyskinesia.
- Understanding these mechanisms may lead to novel therapeutic strategies for movement disorders.
Related Concept Videos
01:24Parkinson's Disease: Treatment
428
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
428
01:15Parkinson's Disease: Overview
804
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
804
01:37Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
01:29Drugs Affecting Neurotransmitter Synthesis
1.7K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.7K
01:21Satellite Stem Cells and Muscular Dystrophy
2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
945
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
945